ARCHFORM BYTE LIMITED

Company number 07365506 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Risk Analysis: Archform Byte Limited (07365506)

1. Risk Rating: HIGH

Justification: The company is technically insolvent with net liabilities of £428,670 and shareholders' deficit of £431,020. It is entirely dependent on unsecured, interest-free director loans (£459,727 combined) to remain operational. Cash reserves stand at £1, presenting severe liquidity risk. While the most recent year shows improvement in trading performance (EBITDA nearly doubled), the balance sheet remains critically impaired and the company would be unable to meet obligations if director support were withdrawn.


2. Key Concerns

Concern 1: Technical Insolvency and Capital Erosion

The company has been in a net liability position since at least 2022, with accumulated losses of £431,020 against share capital of just £2,350. The dramatic deterioration from positive net assets of £460,079 (2019) to negative £475,369 (2022) suggests a significant adverse event—potentially a trading loss, write-down, or reclassification of director loans. The accounts do not explain this transformation, which is a material gap in disclosure.

Concern 2: Extreme Liquidity Risk

Cash at bank of £1 is a critical red flag. Net current liabilities of £28,609 (worsened from £14,733) indicate the company cannot cover short-term obligations from current assets. Trade creditors have increased by 51% (from £18,031 to £27,316), which may signal difficulty in meeting supplier payments. The company is surviving on a cash-flow basis rather than holding any meaningful reserves.

Concern 3: Total Dependence on Director Loans

Approximately £459,727 of director/participator loans (Mrs Hudson-Ward: £245,218; name shown to subscribers: £214,509) plus £24,750 from shareholder Mr Jepson represent the vast majority of long-term liabilities. These loans are unsecured, interest-free, and have no fixed repayment terms. If either director demanded repayment or ceased support, the company would face immediate insolvency. This concentration of financial dependency on two individuals represents significant key-person risk.


3. Positive Indicators

  • Trading Improvement: EBITDA increased substantially from £26,236 (2024) to £44,819 (2025), a 71% improvement suggesting the underlying business is generating stronger operating cash flows.

  • Net Liability Reduction: Total net liabilities improved by approximately £34,465 year-on-year (from £463,135 to £428,670), indicating the company is gradually repairing its balance sheet.

  • Director Commitment: Both directors maintain significant loans with no stated intention of withdrawal. The accounts explicitly state there is "no anticipation of this loan support being withdrawn in the foreseeable future." The gradual repayment schedule (£40,000 maximum per year for Mrs Hudson-Ward's loan) suggests managed, not panicked, withdrawal.

  • Regulatory Compliance: Accounts and confirmation statements are filed on time, with no overdue filings. The company has maintained active status for over 14 years.

  • Tangible Asset Base: Plant and machinery of £46,885 carrying value (cost £139,640) suggests ongoing operational capability in the orthodontic laboratory business.


4. Due Diligence Notes

  1. Historical Capital Erosion: The shift from positive net assets of £460,079 (2019) to negative £475,369 (2022) requires explanation. Was there a major trading loss, impairment, or reclassification? The absence of 2020 and 2021 data prevents full analysis. Request management explanation and any available management accounts.

  2. Cash Management: With £1 cash, investigate how the company manages day-to-day operations. Examine whether there are overdraft facilities, factoring arrangements, or other cash management tools not visible on the balance sheet date. The bank loans (£26,618 current + £2,833 long-term) should be examined for terms and covenants.

  3. Stock Valuation: Stocks remain unchanged at £40,000 across both years. Given the specialized nature of orthodontic products, assess whether this represents saleable inventory or potential obsolescence. No stock movement in a trading company is unusual.

  4. Director Identity Discrepancy: The PSC register lists "name shown to subscribers" while the accounts reference "Mrs Pennie Hudson-Ward" as a director. Clarify whether these are the same individual (likely through marriage/name change) and confirm no disqualification concerns exist.

  5. Other Creditors Composition: Long-term "other creditors" of £444,477 include director loans but the total director loans disclosed (£459,727) exceed this figure. Reconcile the composition of creditor categories to understand the full liability structure.

  6. Lease Commitments: Operating lease commitments of £34,500 represent a significant fixed obligation relative to the company's size. Investigate whether these are property leases and whether they contain break clauses or personal guarantees.

  7. Going Concern Viability: While directors assert going concern is valid, request cash flow forecasts and projections to assess whether EBITDA improvement is sustainable and sufficient to address the structural balance sheet weakness within a reasonable timeframe.


Names of the people mentioned are shown to subscribers. See subscription

Perspective: Investment Risk Assessor · Model: glm-5.1 · Generated 27 August 2026